After promising results in mouse models, researchers are ready to move forward with plans for a trial of xenon gas in humans as a potential treatment for Alzheimer’s disease (AD).
The most prevalent neurodegenerative disorder, AD presents a growing challenge as the global population gets older. Developing an effective treatment for the disease has become more urgent than ever.
In recent years, anti-amyloid antibody treatments have shown promise in slowing disease progression in patients